Abstract
Interprofessional Education (IPE) is increasingly recognised as a transformative approach to strengthening healthcare delivery through enhanced collaboration, communication, and shared learning among healthcare professionals. In South Africa’s public healthcare context marked by complex workloads, skill shortages, and fragmented care effective teamwork is essential for improved service delivery and patient outcomes. This study builds upon a phenomenological investigation that explored healthcare professionals’ experiences and perceptions of IPE as a strategy to enhance clinical competence. Using secondary thematic synthesis, the study developed a thematic framework illustrating how IPE serves as a catalyst for transformative care delivery in public healthcare settings.

Data were drawn from in-depth interviews conducted across four public hospitals in Gauteng Province with multidisciplinary professionals, including nurses, physicians, therapists, and pharmacists. Through iterative thematic analysis and synthesis, six interrelated themes were consolidated: (1) role clarity and understanding of professional boundaries; (2) mutual respect and trust; (3) effective communication; (4) teamwork and collaboration; (5) development of collective clinical competence; and (6) patient-centred and systems-oriented care. These themes were integrated into a conceptual model depicting the mechanisms through which IPE fosters attitudinal, behavioural, and organisational transformation.

The framework demonstrates that IPE enhances professional relationships, strengthens shared decision-making, and promotes integrated service delivery ultimately improving clinical competence and patient outcomes. Moreover, it positions IPE not only as an educational intervention but as a strategic mechanism for organisational learning and sustainable health system improvement. The findings provide an evidence-based foundation for embedding IPE into professional development programmes and policy frameworks aimed at advancing quality, safety, and equity in South African healthcare.

Keywords: Interprofessional education, thematic framework, transformative care, clinical competence, teamwork, public healthcare, South Africa

Abstract
Digital fatigue is pervasive among university instructors, yet rigorous evidence on whether generative AI improves well-being is scarce. We conducted an eight-week staggered multiple-baseline AB–AB reversal with eight lecturers at a private Peruvian university. In intervention phases, participants replaced full readings with a daily ≤200-word ChatGPT summary plus three discussion questions (“content-curation sprint”). Outcomes were self-reported digital fatigue (FDU-24) and automatically logged screen time; analyses were carried out using trend-corrected Tau-U and paired-phase Cohen’s d. Across two intervention cycles, screen exposure fell by about 122 min per day (~29% of baseline) and digital fatigue scores decreased by ~22%. Effects were large and replicated (aggregate TauU = −0.79; d = −1.5 to −2.2). Treatment fidelity averaged 96%, and post-study technology acceptance was high. These findings provide preliminary experimental evidence that a brief, low-friction ChatGPT workflow can simultaneously reduce screen time and alleviate digital fatigue in higher-education faculty, suggesting a dual productivity-and-well-being dividend and positioning generative AI as a Job Demands–Resources “resource” rather than a stressor. Multi-site randomized trials with active controls, longer follow-up, and cost-effectiveness analyses are warranted. Practical implications for faculty development are immediate.

Abstract
The varicella vaccine (VarV) produced by Sinovac (Dalian) obtained World Health Organization (WHO) prequalification in November 2022. However, no direct comparative studies have been conducted between VarV and other WHO-prequalified varicella vaccines. The study aimed to assess the immunogenicity and safety of Sinovac’s VarV compared with Merck Sharp & Dohme’s (MSD) VARIVAX® following a single dose administration. This Phase III, randomized, double-blind, active-controlled, non-inferiority trial conducted in the Philippines. Healthy children aged 12 to 15 months were enrolled. Eligible participants were randomly assigned (1:1) to receive a single dose of varicella vaccine either manufactured by Sinovac (Test group) or MSD (Active control group). Immunogenicity was evaluated 6 weeks after vaccination by enzyme-linked immunosorbent assay. The primary immunogenicity endpoint was seroresponse rate in participants who were seronegative at baseline (varicella-zoster virus antibody concentration ＜ 10 mIU/mL), as well as the secondary endpoint geometric mean concentration (GMC). Adverse events (AEs) were monitored for 6 weeks after vaccination. Among 484 participants analyzed, seroresponse rates were 98.85% and 98.88% in the Test group and Active control group, respectively, with a difference of -0.03% (95% CI: -3.10%, 2.99%). GMCs were 35.73 mIU/mL and 37.34 mIU/mL, respectively, with the ratio of 0.96 (95% CI: 0.86, 1.06). Both immunogenicity endpoints reached the prespecified non-inferiority criteria. Furthermore, the incidence of adverse reactions (ARs) in the Test group was lower than that in the Active control group (38.08% vs 55.51%). Conclusions: Sinovac’s VarV demonstrated non-inferior immunogenicity to WHO-prequalified comparator vaccine (VARIVAX®) and favorable safety profile. These findings indicated that VarV (Sinovac) met WHO standards for varicella vaccine evaluation, supporting its global use consideration.

Abstract
During the recent pandemic, the world has grown more sensitized and concerned about climate change as expressed by the outcomes of the recent COP26 and COP27 conferences in 2021 and 2022, respectively. The mission of the many participant nations was to reduce their dependence on fossil fuels in the generation of electricity, or to embrace a decarbonization process. That is, most nations are committed to rely more and more on clean energy sources such as solar, wind, hydroelectric, geothermic and, of course, nuclear. At this moment the USA still has the world largest fleet of light water reactors (92) which currently produce approximately 50% of the clean electricity consumed in the country. Recent legislation in the USA has provided funds to the private sector to prevent the premature shutdown of operating commercial nuclear power plants. The goal of the US Department of Energy is not only to keep existing nuclear plants operating but also to build new capacity through advanced reactors including micro reactors, small modular reactors, and larger scale Gen III and Gen IV reactors. It is argued that the commercialization of accident tolerant fuels (ATF) in the next quinquennium may contribute to the life extension of current light water reactors.

Biography
Dr. Raul B. Rebak is a corrosion research scientist at General Electric Research in Schenectady, New York since 2007. Previously he was the lead for materials corrosion testing in the Yucca Mountain Project at the University of California Lawrence Livermore National Laboratory. Raul has more than 30 years’ experience in environmental degradation processes of materials in many fields including nuclear power, oil & gas, energy storage, healthcare, transportation, and aerospace. Raul is a Fellow of both NACE International and ASM International.